Biofourmis
-
BioPharma, Consumer / Employer, Devices & Diagnostics, Health Tech
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
-
Remote patient monitoring applications from cancer care to sleep
In response to emailed questions, executives from Biofourmis, Force Therapeutics and Project Ronin shared products they’re developing in remote patient monitoring as part of the broader hospital at home trend.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Artificial Intelligence, BioPharma
Biofourmis adds $300M to ramp up in virtual care, digital therapy clinical trials
The Series D round of funding makes Biofourmis a unicorn valued at $1.3 billion. CEO and founder Kuldeep Singh Rajput said that the new capital will be used to expand his company’s remote-monitoring technologies and continue development of digital therapeutics, both as companions to traditional drugs and as monotherapies.
-
Network with healthcare executives at MedCity INVEST
In our first in-person event in two years, the MedCity INVEST conference March 28-30 at the Ritz Carlton Hotel in Chicago, there will be many opportunities to connect with startups, investors and potential collaboration partners.
-
The prestigious alumni of MedCity INVEST Pitch Perfect contest for healthcare startups
The application window is open for the startup contest Pitch Perfect at INVEST March 28-30 at the Ritz Carlton in Chicago. Here’s a look at some of the participants in the contest and progressed they’ve made on their mission to improve healthcare.
-
Neuroglee looks to Mayo partnership, digital therapeutics to tackle mild cognitive impairment
Neuroglee recently raised $10 million in funding and struck a partnership with Mayo Clinic. It’s building a digital therapeutic and virtual programs for people with mild cognitive impairment.
-
Software to calculate the right dose of medicine for heart failure patients gets breakthrough device designation
Biofourmis, a Boston-based digital health startup, recently received breakthrough designation for its digital therapeutic to help ensure heart failure patients receive medications that are consistent with clinical evidence at the right dose.
-
Devices & Diagnostics, Startups, Health Tech
Softbank leads $100M investment in remote monitoring startup Biofourmis
Biofourmis, a Boston-based company that makes software-based therapeutic platforms, raised $100 million in a series C round led by SoftBank’s second Vision Fund. The company currently has developed a digital therapeutic for heart failure patients with Novartis, and plans to expand into other clinical areas.
-
Artificial Intelligence, BioPharma, Health Tech
Chugai, Biofourmis partner on DTx for pain monitoring
The companies will test Biofourmis’ sensor and artificial intelligence system in a clinical trial of more than 120 women with endometriosis.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Healthcare analytics startup Biofourmis moves into oncology with new acquisition
Biofourmis, a Boston-based startup that uses analytics to predict problems in patients with heart failure, acquired Gaido Health from Takeda Pharmaceuticals. The startup said the deal would help it expand its work into oncology.
-
Massachusetts-based Biofourmis to acquire Zurich wearable company
Biofourmis’s CEO boldly declared the company will become a unicorn and this acquisition is expected to give the startup access to more raw data as it expands its analytics platforms and brings Biovotion’s Everion wearable armband inhouse.
-
Startups, Artificial Intelligence
Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease
The company is moving its headquarters from Singapore to Boston alongside the capital raise.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
